Whether it’s digital marketing, succession planning or practice acquisition, an increasing number of independents are turning to Eyecare Plus to ensure the viability of their business in an ever-changing optometric landscape.
Australian allied health group Healthia – which recently entered the optical arena with a multi-million-dollar acquisition of The Optical Company – has announced two practices will be joining its network. Read more
Australian optometrists are reporting positive results with a homegrown clinical decision support tool that uses artificial intelligence (AI) to analyse retinal images for features of the major blinding eye diseases. Read more
An optometrist whose practice was listed as an exposure site for the recent community COVID-19 outbreak in Sydney is now counting the cost of an eight-day business closure and speculative media reporting she fears has undermined public confidence in her services. Read more
A tax cut for medical and biotech companies generating income from new patents developed in Australia, a further expansion of a traineeship wage subsidy and $19.1 million towards trachoma elimination are the main 2021-22 Federal Budget announcements affecting the ophthalmic sector. Read more
BOC Ophthalmic Instruments has introduced two new slit lamp modules that add digital capabilities to the device, as well as a comprehensive set of dry eye diagnostics. Read more
Essilor’s ‘See More Do More’ advertising campaign is running for a second year to educate consumers about the range of lens technologies available to meet their lifestyle needs and encourage them to visit a local optometrist. Read more
The Therapeutic Goods Administration (TGA) has confirmed a shortage of Prednefrin Forte 10mL eye drops in Australia, which isn’t expected to be available until January next year, but its supplier has confirmed it is working towards providing an alternative product. Read more
New data published in the British Journal of Ophthalmology (BJO) has shown Hoya’s MiyoSmart lens continued to slow myopia progression in children after three years, while patients who switched from single vision lenses had a significant slowdown in their condition. Read more
Trends already shaping modern optometry were set on an even steeper trajectory with the advent of COVID-19. MS HILKE FITZSIMONS explains why Zeiss Vision Care’s future-focused products are well-positioned to support optometry during its next evolution.